Sign Up Today and Learn More About BIRD-C Stock
Invest in or calculate the value of your shares in BIRD-C or other pre-IPO companies through EquityZen's platform.
About BIRD-C Stock
Founded
1998
Industries
Software, Artificial Intelligence, Data and Analytics
BIRD-C (Biotech Innovation Research Development and Consulting) is a privately held R&D biotechnology company based in Vienna, Austria. Since its inception in 1998, BIRD-C, under the leadership of its scientific founder and CEO Prof. Werner Lubitz, has developed innovative solutions to various commercially relevant problems. Over the past couple of years, most of the company’s activities have been focused on the development of a unique, internationally renowned and proprietary technology platform, that allows for the generation of empty bacterial shells, so-called Bacterial Ghosts (BGs). Another platform is the production of bacteriophages (viruses against bacteria) and their use for control of bacterial pathogens and related infections and as diagnostic detection vehicles for bacteria. With many years of R&D experience in the field of infectious diseases and most recently in tumor therapy, we are paving the way to the future of immune-therapy applications using BG platform technology - Bacterial Ghosts Cancer Immunotherapy (BGCI). BIRD-C is an equal opportunity employer, men and women are equally found in all positions.
BIRD-C Management
Leadership team at BIRD-C
Chief Executive Officer
Werner Lubitz
Join now and verify your accreditation status to gain access to:
- BIRD-C current valuation
- BIRD-C stock price
- Available deals in BIRD-C and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in BIRD-C stock?
Accredited investors can buy pre-IPO stock in companies like BIRD-C through EquityZen funds. These investments are made available by existing BIRD-C shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell BIRD-C stock?
Shareholders can sell their BIRD-C stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
